Previous Article in Journal
Semaglutide Therapy and Cardiorenal Risk Management in Type 2 Diabetes: hsCRP as a Biomarker of Risk
 
 
Brief Report

Article Versions Notes

Diabetology 2025, 6(12), 143; https://doi.org/10.3390/diabetology6120143
Action Date Notes Link
article xml file uploaded 27 November 2025 05:13 CET Original file -
article xml uploaded. 27 November 2025 05:13 CET Update -
article pdf uploaded. 27 November 2025 05:13 CET Version of Record -
article html file updated 27 November 2025 05:14 CET Original file -
article xml file uploaded 27 November 2025 09:05 CET Update -
article xml uploaded. 27 November 2025 09:05 CET Update https://www.mdpi.com/2673-4540/6/12/143/xml
article pdf uploaded. 27 November 2025 09:05 CET Updated version of record https://www.mdpi.com/2673-4540/6/12/143/pdf
article html file updated 27 November 2025 09:09 CET Update https://www.mdpi.com/2673-4540/6/12/143/html
Back to TopTop